Primary immunodeficiencies (PIDs) are a heterogeneous group of conditions that result from mutations in over 300 different genes and are characterized by varying degrees of abnormal immune cell ...

BMT is curative in almost 75% of children affected by severe primary immunodeficiencies (PIDs). Recently, the chance of cure has increased thanks to the availability of matched unrelated donors (MUDs) ...

Please provide your email address to receive an email when new articles are posted on . More than 14 million people aged younger than 65 years have compromised immune systems. Delays in diagnosis ...

In a recent study published in Nature Communications, researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. Study: CRISPR-Cas9 ...

CASTELVECCHIO PASCOLI, Italy, Nov. 6, 2025 /PRNewswire/ -- Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived therapies, announces its participation at the International ...

Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroids can lead to CD4 lymphopenia and lower IgG levels. Rituximab therapy can lead to ...

HKUMed achieves a global breakthrough in personalised stem cell treatment for immunodeficiency patients, emphasising the importance of raising awareness. (From right) Dr Philip Li, immunodeficiency ...

Intravenous immunoglobulin (IVIg) is a treatment that can boost antibody levels in people with immunodeficiencies, autoimmune diseases, or inflammatory conditions. It contains antibodies, which are ...

Vanessa Bryant is a Sir Clive McPherson Family Centenary Fellow and Royal Melbourne Hospital DW Keir Fellow and also receives funding from NHMRC, Holmes Grant Charitable trust, WEHI Innovation Fund, ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Allocord Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...